Andrew HarmonSenior Consultant, Strategic Consulting at Latham Biopharm GroupSpeaker
Profile
Mr. Harmon is an experienced life sciences professional with specialization in finance and strategy and a technical background in molecular biology and biotechnology with a focus on drug development and the biomanufacturing process. As a Senior Consultant at LBG, he leads the day-to-day aspects of strategic finance projects, conducts financial modeling and analysis, supports the technical review of new life sciences products, and manages non-dilutive and commercially funded programs across the product lifecycle for innovative products, including manufacturing platforms, biologics, small molecules, and drug delivery devices.